uniQure Investors Alert: Securities Class Action Deadline Approaches in 2026

Investor Alert: uniQure Securities Class Action Deadline Approaching

Attention uniQure N.V. investors! As the deadline for filing a securities class action approaches, prominent law firm Faruqi & Faruqi, LLP is issuing a crucial reminder. Investors who acquired uniQure securities between September 24, 2025, and October 31, 2025, need to act promptly to explore their legal rights. The deadline to seek lead plaintiff status in this federal class action is set for April 13, 2026.

The alarm was sounded when uniQure made disclosures regarding its pivotal study for AMT-130, a treatment for neurological conditions. On November 3, 2025, the company revealed it would not receive adequate support from the FDA for its Biologics License Application (BLA) based on previous studies. This news led to a staggering drop in the company's stock price, decreasing by over 49% in one day.

The proposed complaint highlights critical allegations against uniQure and its executives, asserting violations of federal securities laws through misleading statements. Investors claim they were not adequately informed about uncertainties surrounding the pivotal study’s approval process with the FDA. Lawyers argue that statements made by the company lacked a reasonable basis, which contributed significantly to the loss suffered by many investors.

Faruqi & Faruqi's Senior Partner, James (Josh) Wilson, encourages affected investors to reach out directly to discuss their positions and options. As the lead plaintiff, you can take charge of the direction of the case if you have the most substantial financial interest in the outcome.

This class action lawsuit seeks to remedy the reported losses stemming from uniQure's actions. The law firm has a proven history of recovering significant amounts for investors who have suffered from similar situations. With more than two decades in securities law, Faruqi & Faruqi remains dedicated to protecting investors' rights.

If you suspect you are part of the affected group, now is the time to act. You can reach out to Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss your situation further. Alternatively, visit the firm's website for additional information on this critical class action.

In the backdrop of this situation, it’s also vital to remember that investors are not alone; the firm recommends shareholders, ex-employees, or whistleblowers with insight into uniQure’s conduct to come forward and provide information that could be pivotal for the case.

As the April deadline looms, the urgency for claimants cannot be overstated. Keeping track of ongoing developments is crucial to ensuring you do not miss the opportunity to reclaim your losses. Monitor updates via LinkedIn, X, or Facebook, as Faruqi & Faruqi will post important information as it unfolds.

In conclusion, if you've experienced a financial setback with uniQure’s shares, don't hesitate to explore your options for legal recourse. Faruqi & Faruqi continues to work diligently on behalf of investors, aiming to hold corporations accountable for their actions and mitigate the impact of misleading corporate communications on shareholder value.